Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the Company), a maker of medical devices and supplies and the developer of J-Plasma, a patented surgical product marketed and sold under the Renuvion Cosmetic Technology brand in the cosmetic surgery market, today announced that financial results for the fourth quarter and fiscal year 2018 will be released after the market closes on Wednesday, March 13.

Management will host a conference call at 4:30 p.m. Eastern Time on March 13 to discuss the results of the quarter and to host a question and answer session. To listen to the call by phone, interested parties may dial 844-507-6493 (or 647-253-8641 for international callers) and provide access code 5488443. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Companys website and at: https://event.on24.com/wcc/r/1900035/70A2765E9481475B9D616B41D450F535.

A telephonic replay will be available approximately two hours after the end of the call through March 27, 2019. The replay can be accessed by dialing 800-585-8367 for U.S. callers or 416-621-4642 for international callers and using the replay access code: 5488443. The webcast will be archived on the Investor Relations section of the Companys website.

About Apyx Medical Corporation:

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

Apyx Medical Corporation (formerly Bovie Medical Corporation) is an advanced energy technology company with a passion for elevating peoples lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The companys Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Westwicke Partners on behalf of Apyx Medical Corporation
Mike
Piccinino, CFA
443-213-0500
[email protected]